Page 105 - Read Online

Page 16 of 18 Wallace et al. J Cancer Metastasis Treat 2019;5:9 I http://dx.doi.org/10.20517/2394-4722.2019.01

86. Huang Q, Li F, Liu X, Li W, Shi W, et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med
2011;17:860-6.
87. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
88. Nature reviews Cancer. The tumor microenvironment. Available from: https://www.nature.com/collections/khylqkxqbr/content/reviews. [Last
accessed on 1 Feb 2019]
89. Provenzano PP, Inman DR, Eliceiri KW, Keely PJ. Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene
expression through a FAK-ERK linkage. Oncogene 2009;28:4326-43.
90. McDaniel SM, Rumer KK, Biroc SL, Metz RP, Singh M, et al. Remodeling of the mammary microenvironment after lactation promotes
breast tumor cell metastasis. Am J Pathol 2006;168:608-20.
91. Bemis LT, Schedin P. Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. Cancer
Res 2000;60:3414-8.
92. O’Brien J, Hansen K, Barkan D, Green J, Schedin P, et al. Non-steroidal anti-inflammatory drugs target the pro-tumorigenic extracellular
matrix of the postpartum mammary gland. Int J Dev Biol 2011;55:745-55.
93. Clarke R. Stromelysin-1 promotes mammary carcinogenesis. Breast Cancer Res 1999;1:66605.
94. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell
2005;8:241-54.
95. Walker RA. The complexities of breast cancer desmoplasia. Breast Cancer Res 2001;3:143-5.
96. Kreike B, van Kouwenhove M, Horlings H, Weigelt B, Peterse H, et al. Gene expression profiling and histopathological characterization of
triple-negative/basal-like breast carcinomas. Breast Cancer Res 2007;9:R65.
97. Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, et al. Collagen reorganization at the tumor-stromal interface facilitates
local invasion. BMC Med 2006;4:38.
98. Qiuchen G, Courtney B, Nathan P, Elizabeth M, Pepper S. Mammary gland involution provides a unique model to study the TGF-beta
cancer paradox. J Clin Med 2017;6:10.
99. Nguyen AV, Pollard JW. Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution.
Development 2000;127:3107-18.
100. Imamura T, Hikita A, Inoue Y. The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis. Breast Cancer 2012;19:118-24.
101. Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol 2016;12:325-38.
102. Kang HR, Lee CG, Homer RJ, Elias JA. Semaphorin 7A plays a critical role in TGF-beta1-induced pulmonary fibrosis. J Exp Med
2007;204:1083-93.
103. Gan Y, Reilkoff R, Peng X, Russell T, Chen Q, et al. Role of semaphorin 7a signaling in transforming growth factor β1-induced lung fibrosis
and scleroderma-related interstitial lung disease. Arthritis Rheum 2011;63:2484-94.
104. Reilkoff RA, Peng H, Murray LA, Peng X, Russell T, et al. Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic
pulmonary fibrosis and are implicated in transforming growth factor-β1-induced pulmonary fibrosis. Am J Respir Crit Care Med
2013;187:180-8.
105. Esnault S, Kelly EA, Johansson MW, Liu LY, Han ST, et al. Semaphorin 7A is expressed on airway eosinophils and upregulated by IL-5
family cytokines. Clin Immunol 2014;150:90-100.
106. De Minicis S, Rychlicki C, Agostinelli L, Saccomanno S, Trozzi L, et al. Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis.
Am J Pathol 2013;183:820-30.
107. Kopp MA, Brommer B, Gatzemeier N, Schwab JM, Pruss H. Spinal cord injury induces differential expression of the profibrotic
semaphorin 7A in the developing and mature glial scar. Glia 2010;58:1748-56.
108. Lee Y, Blount KL, Dai F, Thompson S, Scher JK, et al. Semaphorin 7A in circulating regulatory T cells is increased in autosomal-dominant
polycystic kidney disease and decreases with tolvaptan treatment. Clin Exp Nephrol 2018;22:906-16.
109. Esnault S, Torr EE, Bernau K, Johansson MW, Kelly EA, et al. Endogenous semaphorin-7A impedes human lung fibroblast differentiation.
PLoS One 2017;12:e0170207.
110. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-87.
111. Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, et al. Metastatic growth from dormant cells induced by a col-I-enriched
fibrotic environment. Cancer Res 2010;70:5706-16.
112. Eke I, Cordes N. Focal adhesion signaling and therapy resistance in cancer. Semin Cancer Biol 2015;31:65-75.
113. Jiang WG, Sanders AJ, Katoh M, Ungefroren H, Gieseler F, et al. Tissue invasion and metastasis: molecular, biological and clinical
perspectives. Semin Cancer Biol 2015;35 Suppl:S244-S75.
114. Narunsky L, Oren R, Bochner F, Neeman M. Imaging aspects of the tumor stroma with therapeutic implications. Pharmacol Ther
2014;141:192-208.
115. Seguin L, Desgrosellier JS, Weis SM, Cheresh DA. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance.
Trends Cell Biol 2015;25:234-40.
116. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004;5:816-26.
117. Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer 2018;18:533-48.
118. Humphries JD, Byron A, Humphries MJ. Integrin ligands at a glance. J Cell Sci 2006;119:3901-3.
119. Liu H, Juo ZS, Shim AH, Focia PJ, Chen X, et al. Structural basis of semaphorin-plexin recognition and viral mimicry from Sema7A and
A39R complexes with PlexinC1. Cell 2010;142:749-61.
120. Jongbloets BC, Lemstra S, Schellino R, Broekhoven MH, Parkash J, et al. Stage-specific functions of semaphorin7A during adult
hippocampal neurogenesis rely on distinct receptors. Nat Commun 2017;8:14666.
121. Suzuki K, Okuno T, Yamamoto M, Pasterkamp RJ, Takegahara N, et al. Semaphorin 7A initiates T-cell-mediated inflammatory responses
through alpha1beta1 integrin. Nature 2007;446:680-4.